BEAT
HeartBeam, Inc.
NASDAQ · Healthcare · Medical - Healthcare Information Services · US
$0.40
−4.00%Price chart
Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open$0.43
From 52W high−88.29%
Volume279525.00
Market cap$22.70M
P/E (TTM)—
P/S (TTM)—
Div yield—
Key dataSep 18, 2026
Open
$0.43
From 52W high
−88.29%
Volume
279525.00
Market cap
$22.70M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−0.7x
P/E (TTM)
—
RSI (14)
39.0
MomentumView details →
1D Return
−4.00%
YTD Return
−82.53%
SummaryUpdated Jun 1, 2026
HeartBeam, Inc. (NASDAQ:BEAT) is a medical technology company founded in 2015 and headquartered in Santa Clara, California. The company went public in November 2021 and focuses on developing innovative telemedicine solutions for cardiac monitoring and diagnosis outside traditional healthcare facility settings. HeartBeam has developed proprietary technology that enables the creation of a credit card-sized, cable-free electrocardiogram (ECG) device capable of synthesizing a full 12-lead ECG reading, representing a significant advancement in portable cardiac monitoring technology.
Similar companies
Latest newsMore news →
HeartBeam completed enrollment of 120 patients in its ALIGN-ACS pilot study evaluating its portable 3D ECG technology for potential heart-attack detection.3d agoHeartBeam, Inc. signed an at-the-market equity offering sales agreement with Titan Partners Securities LLC, allowing HeartBeam to sell up to $25,000,000 of its common stock from time to time, with Titan Partners receiving a commission of up to 3% of gross sales price.37d ago